Literature DB >> 12025942

Microsatellite analysis of primary and recurrent glial tumors suggests different modalities of clonal evolution of tumor cells.

Eva Gömöri1, Zsolt Fülöp, Istvan Mészáros, Tamas Dóczi, András Matolcsy.   

Abstract

Gliomas are characterized by highly variable biological behavior. After surgical resection and postoperative therapy they frequently recur with the same or higher-grade histology. Although a number of genetic aberrations have been described in gliomas of different histological types, the molecular mechanisms of the histological and clinical progression are poorly understood. In this study, we performed longitudinal microsatellite and mismatch repair gene analysis in paired samples of primary and recurrent gliomas in order to reveal whether genetic instability is associated with tumor progression. The 7 microsatellite loci of the 7 patients displayed a total of 18 (54.5%) alterations in the primary and 15 (45.5%) alterations in the recurrent gliomas as compared with the corresponding non-neoplastic cells, but no alterations were found in the hMLH1 and hMSH2 genes. These results suggest that microsatellite instability is associated with the development of the primary gliomas rather than with the recurrence or progression, and it is not associated with structural alterations in the hMLH1 or hMSH2 genes. Comparison of the microsatellite patterns in primary and secondary gliomas revealed 4 different modalities of clonal evolution, involving clonal identity, clonal deletion, clonal progression, and different clonality, suggesting that intensive clonal selection may play a central part in the recurrence of gliomas.

Entities:  

Mesh:

Year:  2002        PMID: 12025942     DOI: 10.1093/jnen/61.5.396

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  10 in total

1.  Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: a report from the Children's Oncology Group.

Authors:  Ian F Pollack; Ronald L Hamilton; Robert W Sobol; Marina N Nikiforova; Yuri E Nikiforov; Maureen A Lyons-Weiler; William A LaFramboise; Peter C Burger; Daniel J Brat; Marc K Rosenblum; Floyd H Gilles; Allan J Yates; Tianni Zhou; Kenneth J Cohen; Jonathan L Finlay; Regina I Jakacki
Journal:  Pediatr Blood Cancer       Date:  2010-12-01       Impact factor: 3.167

2.  Alterations of p53, BCL-2, and hMSH2 protein expression in the normal brain tissues, gliosis, and gliomas.

Authors:  Mahmoud R Hussein; Rabab M H El-Ghorori; Yasser G Abd El-Rahman
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

3.  Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors.

Authors:  Tapasya Srivastava; Kunzang Chosdol; Parthaprasad Chattopadhayay; Chitra Sarkar; Ashok K Mahapatra; Subrata Sinha
Journal:  J Neurooncol       Date:  2006-10-04       Impact factor: 4.130

4.  Evaluation of microsatellite instability in tumors of central nervous system: A pilot study.

Authors:  Minal Vaish; Raj Kumar; R D Mittal; Balraj Mittal
Journal:  Indian J Clin Biochem       Date:  2004-07

5.  Increased hMSH2 protein expression in glioblastoma multiforme.

Authors:  Tapasya Srivastava; Parthaprasad Chattopadhyay; A K Mahapatra; Chitra Sarkar; Subrata Sinha
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

Review 6.  Identifying new small molecule anti-invasive compounds for glioma treatment.

Authors:  Jennifer Munson; Michael Bonner; Levi Fried; Jonathan Hofmekler; Jack Arbiser; Ravi Bellamkonda
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

7.  Quantification, self-renewal, and genetic tracing of FL1⁺ tumor-initiating cells in a large cohort of human gliomas.

Authors:  Virginie Clément-Schatlo; Denis Marino; Karim Burkhardt; Patrick Teta; Fabienne Leyvraz; Bawarjan Schatlo; Stephan Frank; Karl Schaller; Vincent Castella; Ivan Radovanovic
Journal:  Neuro Oncol       Date:  2012-05-14       Impact factor: 12.300

8.  Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.

Authors:  Elena I Fomchenko; Joseph D Dougherty; Karim Y Helmy; Amanda M Katz; Alexander Pietras; Cameron Brennan; Jason T Huse; Ana Milosevic; Eric C Holland
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

9.  Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro.

Authors:  Monika Witusik-Perkowska; Magdalena Zakrzewska; Malgorzata Szybka; Wielislaw Papierz; Dariusz J Jaskolski; Pawel P Liberski; Beata Sikorska
Journal:  Cancer Cell Int       Date:  2014-08-22       Impact factor: 5.722

10.  Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.

Authors:  David H Gutmann; Michael D McLellan; Ibrahim Hussain; John W Wallis; Lucinda L Fulton; Robert S Fulton; Vincent Magrini; Ryan Demeter; Todd Wylie; Cyriac Kandoth; Jeffrey R Leonard; Abhijit Guha; Christopher A Miller; Li Ding; Elaine R Mardis
Journal:  Genome Res       Date:  2012-12-05       Impact factor: 9.043

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.